294 related articles for article (PubMed ID: 23482315)
1. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
Ibrahim MA
Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
[TBL] [Abstract][Full Text] [Related]
2. Influence of MCC II fraction and storage conditions on pellet properties.
Krueger C; Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
[TBL] [Abstract][Full Text] [Related]
3. The evaluation of formulations for the preparation of pellets with high drug loading by extrusion/spheronization.
Podczeck F; Knight P
Pharm Dev Technol; 2006; 11(3):263-74. PubMed ID: 16895837
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of diclofenac sodium sustained release matrix pellets: impact of polyethylene glycols molecular weight.
Ibrahim A; Shazly A
Acta Pol Pharm; 2014; 71(5):821-31. PubMed ID: 25362811
[TBL] [Abstract][Full Text] [Related]
5. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
Drug Dev Ind Pharm; 2002 Apr; 28(4):451-6. PubMed ID: 12056538
[TBL] [Abstract][Full Text] [Related]
6. Influence of starting material particle size on pellet surface roughness.
Sarkar S; Ang BH; Liew CV
AAPS PharmSciTech; 2014 Feb; 15(1):131-9. PubMed ID: 24198222
[TBL] [Abstract][Full Text] [Related]
7. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
Serratoni M; Newton M; Booth S; Clarke A
Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
[TBL] [Abstract][Full Text] [Related]
8. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
Verheyen P; Steffens KJ; Kleinebudde P
Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
[TBL] [Abstract][Full Text] [Related]
9. Sustained release pellets based on poly(N-isopropyl acrylamide): matrix and in situ photopolymerization-coated systems.
Mayo-Pedrosa M; Alvarez-Lorenzo C; Lacík I; Martinez-Pacheco R; Concheiro A
J Pharm Sci; 2007 Jan; 96(1):93-105. PubMed ID: 16967440
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the coat quality of sustained release pellets by individual pellet dissolution methodology.
Xu M; Liew CV; Heng PWS
Int J Pharm; 2015 Jan; 478(1):318-327. PubMed ID: 25435182
[TBL] [Abstract][Full Text] [Related]
11. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of the rheological properties of lactose/microcrystalline cellulose and water mixtures by controlled stress rheometry and the relationship to the production of spherical pellets by extrusion/spheronization.
MacRitchie KA; Newton JM; Rowe RC
Eur J Pharm Sci; 2002 Oct; 17(1-2):43-50. PubMed ID: 12356419
[TBL] [Abstract][Full Text] [Related]
13. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
Liew CV; Gu L; Soh JL; Heng PW
Pharm Res; 2005 Aug; 22(8):1387-98. PubMed ID: 16078149
[TBL] [Abstract][Full Text] [Related]
14. Preparation and In Vitro-In Vivo Evaluation of Sustained-Release Matrix Pellets of Capsaicin to Enhance the Oral Bioavailability.
Zhang Y; Huang Z; Omari-Siaw E; Lu S; Zhu Y; Jiang D; Wang M; Yu J; Xu X; Zhang W
AAPS PharmSciTech; 2016 Apr; 17(2):339-49. PubMed ID: 26127010
[TBL] [Abstract][Full Text] [Related]
15. Torque rheological parameters to predict pellet quality in extrusion-spheronization.
Soh JL; Liew CV; Heng PW
Int J Pharm; 2006 Jun; 315(1-2):99-109. PubMed ID: 16574352
[TBL] [Abstract][Full Text] [Related]
16. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
[TBL] [Abstract][Full Text] [Related]
17. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
Chatchawalsaisin J; Podczeck F; Newton JM
Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576
[TBL] [Abstract][Full Text] [Related]
18. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.
Goyanes A; Souto C; Martínez-Pacheco R
Pharm Dev Technol; 2010 Dec; 15(6):626-35. PubMed ID: 20148708
[TBL] [Abstract][Full Text] [Related]
19. Supramolecular elucidation of the quality attributes of microcrystalline cellulose and isomalt composite pellet cores.
Antal I; Kállai N; Luhn O; Bernard J; Nagy ZK; Szabó B; Klebovich I; Zelkó R
J Pharm Biomed Anal; 2013 Oct; 84():124-8. PubMed ID: 23827942
[TBL] [Abstract][Full Text] [Related]
20. The influence of non-ionic surfactants on the rheological properties of drug/microcrystalline cellulose/water mixtures and their use in the preparation and drug release performance of pellets prepared by extrusion/spheronization.
Podczeck F; Maghetti A; Newton JM
Eur J Pharm Sci; 2009 Jun; 37(3-4):334-40. PubMed ID: 19491024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
